SMITHKLINE SKB OPENS PLANT IN CHINA PHILADELPHIA Oct SmithKline Beckman Corp said it opened an mln dlr pharmaceutical manufacturing plant in Tianjin China The plant will make pharmaceutical products for the joint venture company Tianjin Smith Kline and French Laboratories SmithKline said the joint venture combines Smith Kline and French Laboratories the pharmaceutical unit of SmithKline Beckman the Tianjin Medical Co and Hebel Chemical Plant in Tianjin The plant has the capability to produce one billion tablets and mln capsules a year Reuter